Relay Therapeutics impresses with robust interim data in mutated breast cancer

Relay Therapeutics is a clinically-focused biotechnology company based in Cambridge, Massachusetts, that aims to change the way drugs are discovered. Instead of concentrating on static protein structures, the company utilizes a unique platform called Dynamo, which combines experimental and computational methods to understand the movement of proteins and thereby unlock previously challenging targets for small molecules. The focus is on targeted therapies for cancer and genetic diseases, including several drug candidates such as the selective PI3Kα-inhibitor...